Latest / Stock Movers / Vistra Deepens AI Bet; Aeva Soars on Nvidia Deal; Microchip Climbs on Sales Beat
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 1: Let's take a look at some stocks on the move today.
- 0:18Speaker 1: I'm Nathan Hager, joined by Bloomberg's Valerie Titel. Starting off
- 0:21Speaker 1: with a stock that's moving on a pretty interesting bet
- 0:24Speaker 1: around AI. What's happening with Vistra. Good morning, Valerie.
- 0:29Speaker 3: Hey, good morning Nathan. You. Vistra is hired by nearly
- 0:32Speaker 3: five percent in pre market trade. It's the largest competitive
- 0:36Speaker 3: power generator in the US, and they have agreed to
- 0:39Speaker 3: buy a gas power fleet for four billion dollars as
- 0:44Speaker 3: it deepens its bet on this energy race around AI.
- 0:48Speaker 3: The deal includes ten power plants, and these gas powered
- 0:52Speaker 3: power plants are seen as ideal sources for that around
- 0:55Speaker 3: the clock data center demand that this AI race will
- 0:59Speaker 3: need SOTRU jumping off of this news hire by four
- 1:02Speaker 3: point seven percent, Okay, and.
- 1:04Speaker 1: You're gonna have to help me out with the name
- 1:06Speaker 1: of this next stock on your list? Is it Ava
- 1:08Speaker 1: Ava Ava Ava?
- 1:11Speaker 3: Now, this is a lie Dar company, a sensor technology essentially,
- 1:16Speaker 3: it is surging in pre market that's what you need
- 1:18Speaker 3: to know, up over thirty percent, Nathan. After Nvidia chose
- 1:22Speaker 3: its laser based technology to power its autonomous driving platform.
- 1:27Speaker 3: It comes alongside a string of new launches from Nvidia
- 1:32Speaker 3: at the CEES trade show in Las Vegas. One of
- 1:34Speaker 3: those was a new vehicle platform called Alpa MAO, which
- 1:38Speaker 3: allows autonomous cars to reason in the real world, essentially
- 1:42Speaker 3: think their way out of unexpected situations. So Nvidia is
- 1:45Speaker 3: aiming to extend their reach of its technology, and it's
- 1:48Speaker 3: including reaching out into autonomous driving platforms with this new
- 1:54Speaker 3: agreement with the Ava Lightar company.
- 1:56Speaker 1: Okay, so we'll keep in mind and Ava from here
- 2:00Speaker 1: on out. I would imagine there's a stock called microchip.
- 2:04Speaker 1: This isn't just the microchip sector in particular that you're
- 2:08Speaker 1: looking at.
- 2:08Speaker 3: You know, I had a double second guest set myself.
- 2:11Speaker 2: Yeah, record Chip.
- 2:13Speaker 3: It's in the news because the analog chip maker had
- 2:16Speaker 3: lifted its sales forecast and essentially points to an early
- 2:21Speaker 3: recovery in the analog A chip sector counts Texas Instruments
- 2:26Speaker 3: as one of its main competitors. We're actually seeing the
- 2:28Speaker 3: likes of many of these analog chip makers rally off
- 2:31Speaker 3: the back of this positive forecast from Microchip. Now, the
- 2:35Speaker 3: analog chip sector has been experiencing a cyclical slump due
- 2:38Speaker 3: to an inventory glut and weakening demand, especially from the
- 2:42Speaker 3: auto space. But the CEO said that activity booking was
- 2:45Speaker 3: very strong in the December quarter and they raised their
- 2:48Speaker 3: guidance off the back of that.
- 2:49Speaker 1: Okay, let's get to some of the names we've heard before.
- 2:52Speaker 1: Nova Nordisk is in the news as well, of course,
- 2:54Speaker 1: because the Wogovi pill is in the US market.
- 2:59Speaker 2: Now.
- 2:59Speaker 3: Yeah, noortis really making some headlines in the European session.
- 3:02Speaker 3: The best performing stock in the eurostock six underd Their
- 3:05Speaker 3: eight rs are higher by just shy of four percent.
- 3:08Speaker 3: The weight loss pill launches in the US just two
- 3:12Speaker 3: weeks after it received US regulatory approval for the drug.
- 3:16Speaker 3: It will be broadly available through seventy thousand pharmacies across the US.
- 3:21Speaker 3: The investor focus will be on the volume benefit as
- 3:24Speaker 3: it tries to compete with Eli Lilly for market share
- 3:26Speaker 3: in this space, and most importantly, on the margins.
- 3:29Speaker 1: All right, and finally, in our last thirty seconds, don't
- 3:32Speaker 1: correct me on the pronunciation, but Adidas is Adidas as well.
- 3:36Speaker 3: Yes, Sinking six percent in Germany, a double downgrade from
- 3:40Speaker 3: Bank of America. They are now calling the twenty year
- 3:43Speaker 3: casualization trend largely complete.
- 3:47Speaker 2: This stock mover's report from Bloomberg Radio. Check back with
- 3:51Speaker 2: us throughout the day for the latest roundup of companies
- 3:54Speaker 2: making news on Wall Street and for the latest market
- 3:57Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:01Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:05Speaker 2: the Bloomberg Business App.